TARDBP and amyotrophic lateral sclerosis: Emerging evidence suggests that TDP-43 mislocalisation in ALS/FTD postmortem tissue correlates with increased m6A-RNA levels, which may disrupt the stability of target RNAs (McMillan et al, 2023).